August 2020 - Page 2 of 3 - PsychedelicNewsWire (PNW)

WednesdayAug 19, 2020 3:30 pm

Johns Hopkins Researchers Invite Real World Psychedelics Users to Share Their Experiences

A team of researchers from Johns Hopkins University are calling on people who use psychedelics to enroll for their new study that is geared at understanding the real-world effects of taking psychedelic substances like shrooms (magic mushrooms). The Johns Hopkins researchers are working together with Unlimited Sciences, a Denver-based nonprofit which is funding this “real-world” study. The intention is to get insights into the factors which impact psychedelic trips and the outcomes of those trips. To this end, the researchers are asking anyone who plans, for whatever reason, to take psychedelics, to enroll. They are also open to people taking…

WednesdayAug 19, 2020 11:45 am

Cybin Corp. Ideally Positioned as Landmark Decision Regarding Psilocybin Therapy Could Spark Increased Interest, Use

Canada’s Minister of Health approves the use of psilocybin therapy in end-of-life care of four Canadians battling incurable cancer The Decision marks first legal, medical exemptions for psilocybin use in Canada since the compound became illegal in 1974 Cybin subsidiary Serenity Life Sciences focuses on advancing R&D of psilocybin-based pharmaceutical products A ground-breaking decision by Canada’s Minister of Health, the Honourable Patty Hajdu, to approve the use of psilocybin therapy in the end-of-life treatment of four Canadians battling incurable cancer (http://ibn.fm/0BUOU) bodes well for companies such as Cybin Corp., which are operating in the psilocybin sector. An exemplary Canada-based, life-sciences company,…

TuesdayAug 18, 2020 2:00 pm

Congressman Says Psychedelics Are a Promising Treatment for PTSD

It is rare to hear anyone on Capitol Hill talking about psychedelics, but Rep. Joe Kennedy III, a Democrat from Massachusetts, has not only changed his stance from being anti-marijuana legalization lawmaker to one in favor of cannabis policy reform and he even said that certain psychedelics show a lot of promise as treatments for depression and post-traumatic stress disorder (“PTSD”). This statement by the Congressman is interesting for a number of reasons. First, Democrats in the House of Representatives heavily voted against an amendment which would have paved the way for research into a number of psychedelics, such as…

TuesdayAug 18, 2020 10:35 am

Pure Extract Technologies Inc. Focused on Becoming Dominant Extraction Company, Poised for Rapid Growth in Expanding Mushroom Market

Vast potential of mushroom medicine market is hindered by lack of pharma-grade extracts preventing brands from seizing this market opportunity Traditional extract producers limited by low-volume, non-scalable manufacturing methods Pure Extracts equipped to produce urgently needed pharma-grade psilocybin Pure Extracts, a Canadian plant-based extraction company operating in the functional medicinal mushrooms space, is in a unique position to become the dominant extraction company and a leader in the rapid development and commercialization of functional medicine products. With its substantial experience and technical competence in plant extraction creating a distinctive competitive advantage, Pure Extracts is focused on becoming a critical partner…

MondayAug 17, 2020 12:41 pm

Cybin Corp. Enters Feasibility Agreement to Develop Fast-Acting Psilocybin Film

Agreement with leading drug-delivery company outlines plans to develop fast-acting, orally dissolving film for delivery of pharmaceutical-grade psilocybin Cybin CEO notes that systemic bioavailability of film is projected to be high Cybin focused on developing fungi-derived psychedelic, medicinal products to treat mental illness, other health conditions Cybin Corp. announced that it has entered into a feasibility agreement with IntelGenx Corp., a leading drug-delivery company focused on the development and manufacturing of pharmaceutical delivery films (http://ibn.fm/TZeVy). The agreement outlines plans for the two companies to develop a fast-acting, orally dissolving film for the delivery of pharmaceutical-grade psilocybin. “We at Cybin are proud…

MondayAug 17, 2020 11:15 am

The Role of Psychedelic Products in Medicinal Treatments

Scientists are embarking on a new frontier in medicinal treatment. The successful use of controlled psychedelic products is becoming widely accepted by universities, government and research institutes and health care organizations to treat a variety of mental health issues, including anxiety and depression. In the last decade, breakthrough findings have been published about the usefulness and application of psychedelic compounds like psilocybin, more commonly referred to as magic mushrooms. Psilocybin is a naturally occurring psychedelic prodrug compound, which is produced by more than 200 species of mushrooms. After obtaining U.S. regulatory approval to research psychedelics in healthy volunteers, Johns Hopkins…

FridayAug 14, 2020 12:15 pm

What is in Your Ayahuasca Brew?

The Amazonian vine ayahuasca has exerted its healing influence far beyond the religious and traditional ceremonies of South America as evidenced by the exploding interest in the plant across the world. However, the complicated legal status of this plant, together with its attractive economic potential, has opened the door for some less than honest practices when preparing the drink, especially regarding the ingredients that go into the cup. According to research (yet to be published) by Helle Kaasik, from the University of Tartu in Estonia and a team from the University of Campinas in Brazil, there is a marked variation…

ThursdayAug 13, 2020 9:25 am

Book Reveals How LSD Helped the Author Deal with Mental Illness

A Really Good Day, a memoir authored by Ayelet Waldman, is causing quite a stir from the time it was published back in 2017. In this book, the author shares her personal experience of how she micro-dosed on LSD in order to improve her mental health and also save her marriage that was on the verge of falling apart. Micro-dosing involves taking one-tenth of the amount of LSD that recreational users take in order to “trip.” These micro-doses are taken at an interval of four days. The internet is awash with anecdotal reports of how people have benefitted from taking…

WednesdayAug 12, 2020 10:45 am

Oregon Officials Outline How Legal Psilocybin and Decriminalized Cannabis Would Affect the State

Taking advantage of a rarely used provision in the laws of Oregon, lawmakers asked the state to provide several analyses showing how the legalization of psilocybin therapy and the decriminalization of marijuana would affect the state. The Oregon Criminal Justice Commission revealed that the decriminalization initiative would result in the reduction of misdemeanor and felony convictions in the state by 91%. This reduction, the officials say, would be substantial in all racial groups. For example, the reduction would be 94% for blacks and Native Americans living in the state, while misdemeanor and felony convictions would reduce by about 82.9% in…

TuesdayAug 11, 2020 1:00 pm

Canada Grants Terminally Ill Patients Permission to Use Magic Mushrooms

The Canadian Health Minister has granted a group of four terminally ill cancer patients exemptions to possess and use magic (psilocybin) mushrooms as part of their end-of-life care. This is a landmark decision since it means that these four people will be the first to legally possess and use psilocybin mushrooms since psychedelics were prohibited decades ago. The patients, through a nonprofit called Therapsil, had submitted their petition to the minister way back in April so that they could be exempted from the country’s laws which bar anyone from possessing and using magic mushrooms. This petition was quickly followed by…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Month: August 2020